Search hospitals
>
Pennsylvania
>
Wynnewood
CCOP - Main Line Health
Claim this profile
Wynnewood, Pennsylvania 19096
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Ovarian Cancer
Conducts research for Colon Cancer
149 reported clinical trials
0 medical researchers
Summary
CCOP - Main Line Health is a medical facility located in Wynnewood, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer, Colon Cancer and other specialties. CCOP - Main Line Health is involved with conducting 149 clinical trials across 194 conditions. There are 0 research doctors associated with this hospital, such as .
Area of expertise
Breast Cancer
CCOP - Main Line Health has run 32 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
CCOP - Main Line Health has run 24 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CCOP - Main Line Health?
CCOP - Main Line Health is a medical facility located in Wynnewood, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer, Colon Cancer and other specialties. CCOP - Main Line Health is involved with conducting 149 clinical trials across 194 conditions. There are 0 research doctors associated with this hospital, such as .
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.